Maternal cytokine production patterns in women with pre-eclampsia

American Journal of Reproductive Immunology

Volumn 54, Issue 1, 2005, Pages 30-37

  Azizieh, Fawaz ^a   Raghupathy, Raj ^a   Makhseed, Ma'asoumah ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Pre eclampsia; Th1 cytokines; Th2 cytokines

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TH1 CELL; TH2 CELL; TROPHOBLAST;

EID: 21244447418     PISSN: 10467408     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2005.00278.x     Document Type: Article

References (41)

1. Sargent IL, Sacks GP, Knight M, Smarason AK, Redman CWG: Immunomodulation in normal pregnancy and preeclampsia. In Reproductive Immunology, SK Gupta (ed.). New Delhi, Narosa Publishing House, 1999, pp. 198-204.
2. Redman CWG, Sargent IL: The immunology of preeclampsia. In Immunology of Pregnancy, G Chaouat (ed.). London, CRC Press, 1993, pp. 205-230.
3. Pipkin FB, Rubin PC: Preeclampsia - the 'disease of theories'. Br Med Bull 1994; 50:381-396.
4. Redman CWG, Sacks DP, Sargent IL: Preeclampsia: an excessive maternal response to pregnancy. Am J Obstet Gynecol 1999; 180:499-506.
5. Maithiesen L, Berg G, Ernerudh J, Skogh T: Lymphocyte subsets and autoantibodies in pregnancies complicated by placental disorders. Am J Reprod Immunol 1995; 33:31-39.
6. Wilczynski JR, Tchorzewski H, Banasik M, Iowacka E, Wieczorek A, Lewkowicz P, Malinowski A, Szpakowski M, Wilczynski J: Lymphocyte subset distribution and cytokine secretion in third trimester decidua in normal pregnancy and preeclampsia. Eur J Obstet Gynecol Reprod Biol 2003; 109:8-15.
7. Belo L, Santos-Silva A, Caslake M, Cooney J, Pereira-Leite L, Quintanilha A, Rebelo I: Neutrophil activation and C-reactive protein concentration in preeclampsia. Hypertens Pregnancy 2003; 22:129-141.
8. Bowen JM, Chamley L, Mitchell MD, Keelan JA: Cytokines of the placenta and extra-placental membranes: biosynthesis, secretion and roles in establishment of pregnancy in women. Placenta 2002; 23:239-256.
9. Wegmann TG, Lin H, Guilbert L, Mosmann TR: Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 1993; 14:353-356.
10. Chaouat G, Meliani AA, Martal J, Raghupathy R, Elliot J, Mosmann TR, Wegmann TG: IL-10 prevents naturally occurring fetal loss in the CBAxDBA/2 mating combination, and local defect in IL-10 production in this abortion-prone combination is corrected by in vivo injection of IFN-ρ. J Immunol 1995; 154:4261-4268.
11. Chaouat G, Menu E, Dy M, Minkowski M, Clark DA, Wegmann TG: Control of fetal survival in CBA × DBA/2 mice by lymphokine therapy. J Reprod Fertil 1990; 89:447-458.
12. Haimovici F, Hill JA, Anderson DJ: The effects of soluble products of activated lymphocytes and macrophages on blastocyst implantation events in vitro. Biol Reprod 1991; 44:69-76.
13. Yui J, Garcia-Lloret M, Wegmann TG, Guilbert L: Cytotoxicity of tumor necrosis factor-α (TNF-α) and gamma-interferon (IFN-γ) against primary human placental trophoblasts. Placenta 1994; 15:819-828.
14. Berkowitz R, Hill JA, Kurtz CB, Anderson DJ: Effects of products of activated leukocytes (lymphokines and monokines) on the growth of malignant trophoblast cells in vitro. Am J Obstet Gynecol 1988; 151:199-203.
15. Romagnani S: T-cell subsets (Th1 versus Th2). Ann Aller Asthma Immunol 2000; 85:9-18.
16. Mosmann TR, Sad S: The expanding universe of T-cell subsets. Immunol Today 1996; 17:138-146.
17. Raghupathy R: Pregnancy: success and failure within the Th1/Th2/Th3 paradigm. Semin Immunol 2001; 13:219-227.
18. Hill JA, Anderson DJ, Polgar K: T helper 1-type cellular immunity to trophoblast in women with recurrent spontaneous abortions. J Am Med Assoc 1995; 273:1933-1958.
19. Marzi M, Vigano A, Trabattoni D, Villa ML, Salvaggio A, Clerici M: Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996; 106:127-133.
20. Raghupathy R, Makhseed M, Azizieh F, Hassan N, Al-Azemi M, Al-Shamali E: Maternal Th1- and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions. Cell Immunol 1999; 196:122-130.
21. Bartha JL, Romero-Carmona R, Escobar-Llompart M, Comino-Delgado R: The relationships between leptin and inflammatory cytokines in women with preeclampsia. Br J Obstet Gynecol 2001; 108:1272-1276.
22. Conrad KP, Miles TM, Benyo DF: Circulating levels of immunoreactive cytokines in women with preeclampsia, Am. J Reprod Immunol 1998; 40:102-111.
23. Nakabayashi M, Sakura M, Takeda Y, Sato K: Elevated IL-6 Midtrimester amniotic fluid is involved with the onset of preeclampsia. Am J Reprod Immunol 1998; 39:329-334.
24. Claman JY, Rapaport V, Repinski C, Naeim F, Chaudhuri G: Analysis of superoxide generation, cytokine production, and adhesion molecular production in normal pregnant and preeclamptic patients. J Soc Gynecol Investig 1997; 4(Suppl.): 192A.
25. Caniggia I, Grisaru-Gravnosky S, Kuliszewsky M, Post M, Lye SJ: Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest 1999; 103:1641-1650.
26. Lim KJ, Odukoya OA, Ajjan RA, Li TC, Weetman AP, Cooke ID: The role of T-helper cytokines in human reproduction. Fertil Steril 2000; 73:136-142.
27. Piccinni MP, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S: Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nature (Med) 1998; 4:1020-1024.
28. Raghupathy R, Makhseed M, El-Shazly S, Azizieh F, Farhat R, Ashkanani L: Cytokine patterns in maternal blood after premature rupture of membranes. Obstet Gynecol 2001; 98:122-126.
29. Makhseed M, Raghupathy R, El-Shazly S, Azizieh F, Al-Harmi J, Al-Azemi M: Proinflammatory maternal cytokine profile in preterm delivery. Am J Reprod Immunol 2002; 49:1-12.
30. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK: Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161:1200-1204.
31. Taylor RN: Immunobiology of preeclampsia. Am J Reprod Immunol 1997; 37:79-86.
32. Omu AE, Al-Azemi MK, Al-Qattan F, Al-Yatama M: Connection between human leukocyte antigens D region and T helper cytokines in preeclampsia. Arch Gynecol Obstet 2004; 269:79-84.
33. Darmochwal-Kolarz D, Rolinski J, Leszczynska-Gorzelak B, Oleszczuk J: The expression of intracellular cytokines in the lymphocytes of preeclamptic patients. Am J Reprod Immunol 2002; 48:381-386.
34. Saito S, Sakai M, Sasaki Y, Tanebe K, Tsuda H, Michimata T: Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol 1999; 117:550-555.
35. Rein DT, Schondorf T, Gohring UJ, Kurbacher CM, Pinto I, Breidenbach M, Mallmann P, Kolhagen H, Engel H: Cytokine expression in peripheral blood lymphocytes indicates a switch to T helper cells in patients with preeclampsia. J Reprod Immunol 2002; 54:133-142.
36. Saito S, Umekage H, Sakamoto Y, Sakai M, Tanebe K, Sasaki Y, Morikawa H: Increased T helper-1-type immunity and decreased T helper-2-type immunity in patients with preeclampsia. Am J Reprod Immunol 1999; 41:297-306.
37. Williams MA, Farrand A, Mittendorf R, Sorensen TK, Zingheim RW, O'Reilly GC, King IB, Zebelman AM, Luthy DA: Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia. Am J Epidemiol 1999; 149:323-329.
38. Conrad KP, Benyo DF: Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 1997; 37:240-249.
39. Hung TH, Charnock-Jones DS, Skepper JN, Burton GJ: Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am J Pathol 2004; 164:1049-1061.
40. Dekker GA, Sibai BM: Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998; 179:1359-1375.
41. Knackstedt M, Ding JW, Arck PC, Hertwig K, Coulam CB, August C, Lea R, Dudenhausen JW, Gorczynski RM, Levy GA, Clark DA: Activation of the novel prothrombinase, fg12, as a basis for the pregnancy complications spontaneous abortion and preeclampsia. Am J Reprod Immunol 2001; 46:196-210.